Aaron Lukas concentrates his practice in complex patent cases for clients in the pharmaceutical, biotechnology, and semiconductor industries. Aaron is a registered patent attorney and focuses his practice on the representation of generic pharmaceutical companies in Hatch-Waxman litigation.
His practice also includes representing clients preparing patentability, infringement, and invalidity opinions, as well as preparing and prosecuting U.S. and foreign patent applications.
Aaron has provided opinions and drafted and prosecuted patent applications in a wide range of high technology fields, including pharmaceuticals, therapeutic methods, nanotechnology, gene synthesis, recombinant DNA technology, diagnostic assays, and semiconductor devices.
Aaron has research experience in organic chemistry, nanotechnology, and semiconductors. Prior to attending law school, Aaron was a senior research scientist at Air Products and Chemicals, Inc. where he researched next generation thin film precursors and deposition methods for use in flat panel displays, interconnects and other high tech applications (2001-2005).
That research has resulted in 18 issued patents. Aaron’s research experience also includes work as a graduate research assistant at Northwestern University’s International Center for Nanotechnology and Department of Chemistry, where as a part of his doctoral research he synthesized and studied light-absorbing organic molecules for use as molecular switching devices (1996-2001). He is also a graduate of Georgetown Law, and earned bachelor’s degrees in chemistry and humanities, cum laude, from Seattle University.
- Represented Endo Pharmaceuticals Inc. and Strakan International S.à r.l. against Watson Labs’ attempt to make a generic version of Endo’s FORTESTA® product. Following a bench trial, the judge ruled in our clients’ favor on all contested issues and rejected the defendant’s claims of non-infringement, invalidity, and unenforceability. Successfully argued on appeal with the Federal Circuit affirming the trial court decision.
- Represented Innolux Corporation in a patent infringement action involving an improved method of producing LCD products that reduces the number of photolithographic steps required. Won summary judgment of invalidity based on indefiniteness.
- Represented Apotex Inc. in a patent infringement action regarding Apotex’s ANDA to make a generic version of PRISTIQ® (desvenlafaxine). Settled prior to trial.
- Represented Apotex Inc. in a patent infringement action regarding Apotex’s ANDA to make a generic version of AVODART® (dutasteride). Settled prior to trial.
- Represented Apotex Inc. in a patent infringement action regarding Apotex’s ANDA to make a generic version of Sprix® (Ketorolac Tromethamine Nasal Solution).
- Represented Sandoz Inc. in a patent infringement action regarding Sandoz’s ANDA to make a generic version of Roche’s VALCYTE® (valganciclovir hydrochloride).
- Represented Sandoz Inc.in a patent infringement action regarding Sandoz’s ANDA to make a generic version of Abbott’s ZEMPLAR® (paricalcitol). Settled prior to trial.
- Georgetown University Law Center, J.D., 2010
- Northwestern University, Ph.D., 2001
- Seattle University, B.A., 1996
- Seattle University, B.S., cum laude, 1996
BAR ADMISSIONS :
- District of Columbia
- United States Patent and Trademark Office
COURT ADMISSIONS :
- U.S. Court of Appeals for the Federal Circuit
- U.S. Supreme Court
Rate : $$$$